Genting Singapore - Maybank Research 2023-03-20: Increasingly Likely Mass Market Will Exceed Pre-COVID Levels

• We lift our FY23-25 earnings estimates for Genting Singapore (SGX:G13) by 18%-20% and DCF-based target price for Genting Singapore by 23%. With 15% upside from the current Genting Singapore's share price, we upgrade Genting Singapore to BUY from HOLD.
• - Read this at SGinvestors.io -
• Also, seat capacity from China to Singapore suggests that Chinese visitorship could recover to pre-COVID levels by year-end.

Singapore mass market above pre-COVID levels

• - Read this at SGinvestors.io -
• In theory, this should not have happened because Chinese visitors only returned to Singapore from 8 Jan 2023.
• We gather that this is due to Singapore’s booming property prices which created a lot of wealth and drove Singaporeans’ propensity to gamble.

It could go even higher like Las Vegas…

• Read more at SGinvestors.io.

Above is an excerpt from a report by Maybank Research.
Clients of Maybank Securities may be the first to access the full PDF report @ https://www.maybanktrade.com.sg/.

Read also Maybank's most recent report:
2025-02-21 Genting Singapore - Decent End To 2024.

Previous report by Maybank:
2024-11-08 Genting Singapore - Was Not A Great Quarter But Still Deep In Value.

Price targets by 3 other brokers at Genting Singapore Target Prices.

Listing of research reports at Genting Singapore Analyst Reports.

Relevant links:
Genting Singapore Share Price History,
Genting Singapore Announcements,
Genting Singapore Dividend Payout Dates & Corporate Actions,
Genting Singapore News